Pharmaceutical & biotechnology companies dominated the biologics safety testing products market in 2025 with a share of 56.0%. North America accounted for the largest market share, by region, in 2025: ...
SUZHOU, China, June 18, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Biosafety Testing ...
DUBLIN--(BUSINESS WIRE)--The "Biologics Development and Manufacturing Testing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. This report aims to provide ...
The introduction of biologicals into our drug armamentarium is complicating stability testing. For these complex molecules neither physicochemical data nor bioassays alone provide the complete picture ...
DELRAY BEACH, Fla., May 4, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Biologics Safety Testing is projected to grow from about USD 5.57 billion in 2026 to USD 9.66 billion by 2031, at a ...
SUZHOU, China, June 18, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that its Biosafety Testing ...
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=34624144 The growth of advanced modalities such as cell & gene therapies and mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results